Cuprina Holdings [Cayman] Limited (CUPR)

$0.74 0.00 (-0.03%)
Market Cap 15.42M
Revenue (ttm) 48,321.00
Net Income (ttm) -1.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,229.52%
Debt to Equity Ratio 0.00
Volume 37,350
Avg Vol 1,811,492
Day's Range N/A - N/A
Shares Out 21.00M
Stochastic %K 10%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the va...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 65 8512 7275
Address:
Blk 1090, Lower Delta Road #06-08, Singapore, Singapore
Aguilar97
Aguilar97 Nov. 18 at 10:46 PM
$CUPR ughhh 70 cents 🙃🙃
1 · Reply
AlienTrador
AlienTrador Nov. 18 at 7:02 PM
$CUPR news , but no movements? WTH?
1 · Reply
Heidne
Heidne Nov. 18 at 4:11 PM
$CUPR Now it will fly. Skyline highlights an important update from our client Cuprina Wound Care Solutions (Nasdaq CUPR). Today, the Company announced a joint venture with Aiodine Laboratory to co-develop a novel iodine-based wound care solution using Aiodine’s proprietary technology. The partnership will focus on creating advanced antiseptic solutions for chronic and acute wounds, with clinical studies planned to begin in 2026 as part of the regulatory pathway. Cuprina will lead global sales and marketing, while Aiodine brings deep technical expertise. Early study results show strong potential for improved wound healing and reduced infection rates. As the global wound care market grows from $21 billion in 2024 toward a projected $36 billion by 2032, this joint venture positions Cuprina to expand its footprint with meaningful innovation in the space. 🔗 Read more here: https://lnkd.in/ePnRyR-Y
0 · Reply
SkylineCCG
SkylineCCG Nov. 18 at 3:33 PM
Skyline highlights an important update from our client Cuprina Wound Care Solutions $CUPR . Today, the Company announced a joint venture with Aiodine Laboratory to co-develop a novel iodine-based wound care solution using Aiodine’s proprietary technology. The partnership will focus on creating advanced antiseptic solutions for chronic and acute wounds, with clinical studies planned to begin in 2026 as part of the regulatory pathway. Cuprina will lead global sales and marketing, while Aiodine brings deep technical expertise. Early study results show strong potential for improved wound healing and reduced infection rates. As the global wound care market grows from $21 billion in 2024 toward a projected $36 billion by 2032, this joint venture positions Cuprina to expand its footprint with meaningful innovation in the space. 🔗 Read more here: https://ca.finance.yahoo.com/news/cuprina-forms-joint-venture-company-133000329.html Skyline is paid by $CUPR for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
1 · Reply
Aguilar97
Aguilar97 Nov. 18 at 2:09 PM
$CUPR these are all fluff prs
0 · Reply
RoryRoar
RoryRoar Nov. 18 at 2:07 PM
$CUPR Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy https://finance.yahoo.com/news/cuprina-forms-joint-venture-company-133000329.html
0 · Reply
AlienTrador
AlienTrador Nov. 18 at 12:35 PM
$CUPR nice 0 volume
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 17 at 9:59 PM
$CUPR today was day 23 < 1, will they wait until the last minute? :)
1 · Reply
AlienTrador
AlienTrador Nov. 17 at 5:55 PM
$CUPR nice pop
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 17 at 2:24 PM
$CUPR makes me always itchy :)
0 · Reply
Latest News on CUPR
Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

Oct 27, 2025, 8:40 AM EDT - 22 days ago

Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Oct 6, 2025, 8:30 AM EDT - 6 weeks ago

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

Sep 9, 2025, 8:05 AM EDT - 2 months ago

Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

Aug 11, 2025, 12:28 PM EDT - 3 months ago

Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets

EPSM FLYE MIMI PTHL QMMM STFS

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

Jul 21, 2025, 9:00 AM EDT - 4 months ago

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

Cuprina Provides Update on Research Studies with Three Leading Education Institutes

Jun 30, 2025, 8:00 AM EDT - 5 months ago

Cuprina Provides Update on Research Studies with Three Leading Education Institutes

Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

Jun 4, 2025, 8:00 AM EDT - 5 months ago

Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries

Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

May 8, 2025, 1:05 PM EDT - 6 months ago

Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

May 5, 2025, 12:29 PM EDT - 7 months ago

Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

May 5, 2025, 12:27 PM EDT - 7 months ago

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

May 5, 2025, 12:24 PM EDT - 7 months ago

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility

Apr 12, 2025, 1:30 AM EDT - 7 months ago

U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility

AIRO ATHR CHA CIIT FATN IOTR MB

Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO

Mar 7, 2024, 9:55 PM EST - 1 year ago

Singapore-based Cuprina Holdings, which makes wound care products, files for a $10 million US IPO

Cuprina Holdings IPO Registration Document (F-1)

Mar 7, 2024, 4:09 PM EST - 1 year ago

Cuprina Holdings IPO Registration Document (F-1)

Aguilar97
Aguilar97 Nov. 18 at 10:46 PM
$CUPR ughhh 70 cents 🙃🙃
1 · Reply
AlienTrador
AlienTrador Nov. 18 at 7:02 PM
$CUPR news , but no movements? WTH?
1 · Reply
Heidne
Heidne Nov. 18 at 4:11 PM
$CUPR Now it will fly. Skyline highlights an important update from our client Cuprina Wound Care Solutions (Nasdaq CUPR). Today, the Company announced a joint venture with Aiodine Laboratory to co-develop a novel iodine-based wound care solution using Aiodine’s proprietary technology. The partnership will focus on creating advanced antiseptic solutions for chronic and acute wounds, with clinical studies planned to begin in 2026 as part of the regulatory pathway. Cuprina will lead global sales and marketing, while Aiodine brings deep technical expertise. Early study results show strong potential for improved wound healing and reduced infection rates. As the global wound care market grows from $21 billion in 2024 toward a projected $36 billion by 2032, this joint venture positions Cuprina to expand its footprint with meaningful innovation in the space. 🔗 Read more here: https://lnkd.in/ePnRyR-Y
0 · Reply
SkylineCCG
SkylineCCG Nov. 18 at 3:33 PM
Skyline highlights an important update from our client Cuprina Wound Care Solutions $CUPR . Today, the Company announced a joint venture with Aiodine Laboratory to co-develop a novel iodine-based wound care solution using Aiodine’s proprietary technology. The partnership will focus on creating advanced antiseptic solutions for chronic and acute wounds, with clinical studies planned to begin in 2026 as part of the regulatory pathway. Cuprina will lead global sales and marketing, while Aiodine brings deep technical expertise. Early study results show strong potential for improved wound healing and reduced infection rates. As the global wound care market grows from $21 billion in 2024 toward a projected $36 billion by 2032, this joint venture positions Cuprina to expand its footprint with meaningful innovation in the space. 🔗 Read more here: https://ca.finance.yahoo.com/news/cuprina-forms-joint-venture-company-133000329.html Skyline is paid by $CUPR for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
1 · Reply
Aguilar97
Aguilar97 Nov. 18 at 2:09 PM
$CUPR these are all fluff prs
0 · Reply
RoryRoar
RoryRoar Nov. 18 at 2:07 PM
$CUPR Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy https://finance.yahoo.com/news/cuprina-forms-joint-venture-company-133000329.html
0 · Reply
AlienTrador
AlienTrador Nov. 18 at 12:35 PM
$CUPR nice 0 volume
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 17 at 9:59 PM
$CUPR today was day 23 < 1, will they wait until the last minute? :)
1 · Reply
AlienTrador
AlienTrador Nov. 17 at 5:55 PM
$CUPR nice pop
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 17 at 2:24 PM
$CUPR makes me always itchy :)
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 17 at 2:23 PM
$CUPR 12k shares pre-market .. usually nothing ofc, but for this 100k per day stock almost huge :)
0 · Reply
davidwolf0
davidwolf0 Nov. 15 at 1:11 AM
$CUPR If the gov is back up, shouldn't they be approving something? Can't remember what it needed here
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 14 at 2:58 PM
$CUPR zero volume alike so far and down, 10 days into 180 day non-compliance vs known weird situation. I wish this would get more attention.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 14 at 2:46 PM
$CUPR well, it is about time to move it back up. Still mind boggling that it wasn't recovered back up since the attack.
0 · Reply
AlienTrador
AlienTrador Nov. 14 at 2:33 PM
$CUPR ZZZZZ
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 14 at 1:34 PM
$CUPR natural would healing. IPO last April at $4/sh for $12M cash most on the balance sheet, very low float ~6M or so, beaten down for _no_reason_ on 8/15 from $9. Awaiting: Maggot therapy launch of EMEA license, 2nd FDA licence. Got US expert Dr Sherman and one of his FDA license. Plus a new wound treatment in development on top of that. I probably forgot a lot here, but there you have it.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 13 at 8:32 PM
$CUPR expecting a significant update within 1-3 weeks.
0 · Reply
Heidne
Heidne Nov. 13 at 1:21 PM
$CUPR Thank you for your email. We aim to release our first half results by end-November to early December, ahead of the filing deadline. Separately, we will post our full year FY2025 results within the required reporting timeframe in accordance with Nasdaq’s reporting requirements. All filings will be posted on our corporate website once submitted. Thank you, and please feel free to let me know if you have any further questions. Regards, Cuprina Holdings IR Team
1 · Reply
AlienTrador
AlienTrador Nov. 13 at 12:45 PM
$CUPR
1 · Reply
AlienTrador
AlienTrador Nov. 13 at 12:37 PM
$CUPR bid .55 ASK .98? A .43 CENTS SPREAD? THIS IS A SLEEPING GIANT
0 · Reply
AlienTrador
AlienTrador Nov. 13 at 11:58 AM
$CUPR welcome to the .70s fellow bag holders im sitting on 10k shares down $10K LOL Gotta be patient
0 · Reply
AlienTrador
AlienTrador Nov. 12 at 9:04 PM
$CUPR yet another crashing afterhours
1 · Reply